Malnutrition

CYMBIOTIKA EXPANDS INTO AUSTRALIAN MARKET WITH LAUNCH OF NEW WEBSITE

Retrieved on: 
Monday, January 17, 2022
Metabolism, Multimedia, Health, Sugar, Nutrient, Growth, Ageing, Probiotic, Longevity, SAN, Malnutrition, Bundle, Immunity, Online shopping, Dietary supplement

SAN DIEGO, Jan. 17, 2022 /PRNewswire/ -- Cymbiotika , a leading nutritional supplement brand known for creating pure, clinically-backed supplements, today announced the launch of its new Australian website along with a fulfillment center in Victoria.

Key Points: 
  • SAN DIEGO, Jan. 17, 2022 /PRNewswire/ -- Cymbiotika , a leading nutritional supplement brand known for creating pure, clinically-backed supplements, today announced the launch of its new Australian website along with a fulfillment center in Victoria.
  • Website visitors can utilize Cymbiotika's Bundle & Save options and Rewards program to maximize optimal health benefits, while saving long-term.
  • "This exciting expansion into the Australian market is a key milestone in our global strategy.
  • From metabolism and recovery to immunity and brain health, Cymbiotika has a holistic solution for various needs and health goals.

Global Enteral Feeding Pumps Industry to 2026 - Advancements in Enteral Nutritional Pumps to Boost Market Prospects - ResearchAndMarkets.com

Retrieved on: 
Friday, January 14, 2022
Medical Supplies, Health, CAGR, Patient, Enteral administration, Central nervous system, CNS, Weight loss, COVID-19, Population, Safety, Growth, Malnutrition, Lists of diseases, Prevalence, Pet, Cancer

The "Enteral Feeding Pumps - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Enteral Feeding Pumps - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Enteral Feeding Pumps estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2026, growing at a CAGR of 5.6% over the analysis period.
  • This segment currently accounts for a 29.8% share of the global Enteral Feeding Pumps market.
  • The U.S. Market is Estimated at $398.6 Million in 2021, While China is Forecast to Reach $159.5 Million by 2026
    The Enteral Feeding Pumps market in the U.S. is estimated at US$398.6 Million in the year 2021.

2022 Insights on Emerging Protein Alternatives for the Dairy Industry: Synthetic Biology for Closer Cheese Substitutes Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, January 14, 2022
Retail, Health, Fitness & Nutrition, Agriculture, Natural Resources, Food, Beverage, Meat, Research, Veganism, Malnutrition, Breast milk, Adoption, Growth, Yogurt, Diet, Bacteria, Cheese, Millennials, Dairy, Traction, Generation Z, Organization, Butter, Fungus, Feed manufacturing, Milk

This research service focuses on providing a snapshot of current and emerging protein sources to develop dairy products.

Key Points: 
  • This research service focuses on providing a snapshot of current and emerging protein sources to develop dairy products.
  • This research focuses on the following alternative protein sources used in the development of dairy product alternatives for animal protein-based milk, cheese, butter, and yogurt.
  • What are the factors driving research efforts and innovations regarding emerging protein sources in the dairy industry?
  • What are the growth opportunities that emerging protein alternative sources in the dairy industry present?

Worldwide IV Tubing Sets and Accessories Industry Report to 2027 - ResearchAndMarkets.com

Retrieved on: 
Friday, January 14, 2022
Medical Supplies, Health, Dehydration, USD, CAGR, Patient, Nutrient, Time-invariant system, Industry, Malnutrition, Government, Investment, Medical device

The "Global IV Tubing Sets and Accessories Market Report and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global IV Tubing Sets and Accessories Market Report and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • According to this report the global IV tubing sets and accessories market attained a value of about USD 3563.5 million in 2021.
  • The IV tubing sets and accessories industry is being driven by the growing incidences of cardiovascular ailments and the rising issue of malnutrition worldwide.
  • These factors are expected to positively impact the market growth of the global IV tubing sets and accessories industry.

Insights on the IV Tubing Sets and Accessories Global Market to 2026 - Increasing Demand for Infusion Therapy Presents Opportunties - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 13, 2022
Medical Supplies, Health, CAGR, Patient, Profile, Ansoff Matrix, Competitive analysis, Porter's five forces analysis, Growth, Malnutrition, User (computing), Global, Geography, Industry, COVID-19, USD, Observation, Impact, Investment, Medical device, Retail

The Global IV Tubing Sets and Accessories Market is estimated to be USD 1.76 Bn in 2021 and is expected to reach USD 2.37 Bn by 2026, growing at a CAGR of 6.1%.

Key Points: 
  • The Global IV Tubing Sets and Accessories Market is estimated to be USD 1.76 Bn in 2021 and is expected to reach USD 2.37 Bn by 2026, growing at a CAGR of 6.1%.
  • The increasing number of patients dependent on IV fluid transmission has increased the demand for manufacturing IV accessories.
  • A constant need for fluid administration and delivery at automated time intervals is enhancing the growth of the global IV tubing sets and accessories market.
  • The report offers a comprehensive evaluation of the Global IV Tubing Sets and Accessories Market.

Longeveron Announces Publication of Lomecel-B Phase 2b Trial Design in Journal of Frailty and Aging

Retrieved on: 
Wednesday, January 12, 2022
Hypoplastic left heart syndrome, Forward-looking statement, HLHS, Patient, Ageing, Intention, Cognition, Safety, Journal, Malnutrition, Muscle, SEC, Weight loss, Adult, NASDAQ, Achievement, CEO, National Academy of Medicine, Efficacy, GLOBE, National Institute, Bone marrow, National Institute on Aging, Metabolic syndrome, Regenerative medicine, Inflammation, Fatigue, Goal, Intussusception (medical disorder), Company, Disorder, Rationale, Microsoft, Immune system, Patent, Infection, FDA, Cell, National academy, Partnership, Terminology, Pharmaceutical industry, Dietary supplement, Frailty

MIAMI, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or the "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and certain life-threatening conditions, announced today publication of the design and rationale from its recently completed Phase 2b aging frailty clinical trial with Lomecel-B in the Journal of Frailty and Aging .

Key Points: 
  • MIAMI, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or the "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and certain life-threatening conditions, announced today publication of the design and rationale from its recently completed Phase 2b aging frailty clinical trial with Lomecel-B in the Journal of Frailty and Aging .
  • This peer-reviewed article describes the design of the trial which investigated Lomecel-B, a living cell therapy product, as a regenerative medicine strategy for the treatment of frailty in older adults.
  • Aging Frailty is a life-threatening geriatric condition, which studies have estimated affect approximately 15% of Americans over the age of 65, or 8.1 million individuals.
  • Despite the pressing need for interventions, there are no FDA-approved therapies that can slow down, reverse, or prevent Aging Frailty.

Study finds Positive Impact Dietary Supplements Have on Quality of Life for Cancer Patients

Retrieved on: 
Tuesday, January 11, 2022
NHANES, Research, Patient, News, Pharmavite, National Health and Nutrition Examination Survey, Gaps, LinkedIn, Nutrient, QALY, Population, Science, Malnutrition, Disease, Solution, Survivor, MEPS, Dietary supplement, VP, Health, Quality-adjusted life year, Quality of life, Food, National Health, Conditional sentence, Medical Expenditure Panel Survey, Technology, HCP, Risk, Hospital, QOL, Cancer

The cost of hospitalization for those with chronic disease can also impact quality of life.

Key Points: 
  • The cost of hospitalization for those with chronic disease can also impact quality of life.
  • Led by Pharmavite, the makers of Nature Made vitamins and supplements, the study found that cancer survivors who use dietary supplements reported a higher QOL compared to survivors who did not use supplements.
  • Supplement use was associated with an additional 0.48 QALY (Quality Adjusted Life Years; a unit of measure used in the prediction of both quality and duration of life after medical or surgical treatment).
  • "This study reveals the need for dietary supplementation to be part of the post-treatment conversation between patients and their health care providers."

CYMBIOTIKA CEO RECOGNIZED AS MOST INNOVATIVE CEO OF THE YEAR 2021 BY TYCOON SUCCESS

Retrieved on: 
Friday, January 7, 2022
Longevity, Stock, View, Nutrient, Radio, Director, Alternative, AUE, Malnutrition, History, Elmi, Ageing, Sugar, Health, CEO, Melody Day (group), Genetically modified organism, Board, Entrepreneurship, SAN, Reuters - The World's Most Innovative Universities, Dash Radio, Multimedia, Leadership, Management, EU

SAN DIEGO, Jan. 7, 2022 /PRNewswire/ -- Cymbiotika , a leading nutritional supplement brand known for creating pure, clinically backed supplements, recently celebrated Co-Founder and CEO Shahab Elmi's recognition as the Most Innovative CEO of the Year 2021 by Tycoon Success .

Key Points: 
  • SAN DIEGO, Jan. 7, 2022 /PRNewswire/ -- Cymbiotika , a leading nutritional supplement brand known for creating pure, clinically backed supplements, recently celebrated Co-Founder and CEO Shahab Elmi's recognition as the Most Innovative CEO of the Year 2021 by Tycoon Success .
  • An annual listing by Tycoon Success, the Most Innovative CEO Award seeks to identify and honor leaders that are effortlessly redefining the business world with their creative blend of information.
  • The publication aims to promote a culture cementing entrepreneurial activities and modern business windows to exchange views, opinions, and drive business growth.
  • "I'm grateful for the support of my team and humbled to be recognized by Tycoon Success," said Shahab Elmi, Co-Founder and CEO of Cymbiotika.

Global Enteral Nutrition Market to 2030 - by Nutrient, Application, Category, Product Form, End User, Distribution Channel and Region - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 6, 2022
Medical Supplies, Medical Devices, Health, Hospitals, Fitness & Nutrition, General Health, Research, Adoption, Parenteral nutrition, Patient, Incidence, Malnutrition, Conditional sentence, Administration, Nutrient, Agriculture, Risk management

The "Global Enteral Nutrition Market 2020-2030 by Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Enteral Nutrition Market 2020-2030 by Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.
  • The global enteral nutrition market will reach $19.75 billion by 2030, growing by 8.9% annually over 2020-2030 driven by the increasing incidence of malnutrition, rising number of patients suffering with chronic diseases, and surge in adoption of enteral nutrition over parenteral nutrition due to lower cost and complications of enteral nutrition.
  • The report is based on a comprehensive research of the entire global enteral nutrition market and all its sub-segments through extensively detailed classifications.
  • Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain.

The Worldwide Pet Meal Kit Delivery Services Industry is Expected to Reach $5.2 Billion by 2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 5, 2022
Retail, Online Retail, Pets, Consumer, Farmer, PETS, Spot, Taste, Growth, Chapter Three, Meal, Awareness, USD, Nutritional deficiency eczema, Support Dogs, Inc., Dog, Malnutrition, List, Allergy, Fast food

The dogs animal type segment led the market and accounted for the leading share of the total revenue in 2020.

Key Points: 
  • The dogs animal type segment led the market and accounted for the leading share of the total revenue in 2020.
  • Furthermore, with a rise in the cases of dog diseases due to nutritional deficiency, there is an increase in demand for meal kit delivery services to provide calculated meals based on the dog's profile.
  • For instance, in April 2020, Spot & Tango, U.S., received a seed funding of USD 4.2 million to launch their dry pet meal services across the globe.
  • Pet Meal Kit Delivery Services Market Variables, Trends & Scope